Form 4: HCA Exec McAlevey Boosts Stake After Performance Vesting

HCA Healthcare's EVP & Chief Legal & Admin Officer, Michael R. McAlevey, acquired 8,372 shares of common stock following the vesting of performance share units, while also disposing of shares for tax purposes.

Summary

• Michael R. McAlevey, EVP & Chief Legal & Admin Officer of HCA Healthcare, Inc., reported transactions involving HCA common stock.
• On February 10, 2026, McAlevey acquired 8,372 shares of common stock.
• This acquisition resulted from the vesting of 4,186 performance share units granted on January 30, 2023, which vested at 200% due to HCA's strong cumulative EPS performance for fiscal years 2023-2025.
• Concurrently, McAlevey disposed of 3,006 shares of common stock at a price of $502.05 per share, likely to cover tax obligations related to the vesting.
• Following these transactions, McAlevey directly owns 8,853 shares and indirectly owns 2,111 shares via a 2024 GRAT and 26 shares via a managed account.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive indicator of strong past financial performance and executive alignment, despite the routine tax-related share disposition.

Positives

• Vesting of performance share units at 200% of target indicates HCA Healthcare exceeded its cumulative earnings per share goal for fiscal years 2023-2025, achieving 110% or more of the target.
• The executive's net increase in direct beneficial ownership (8,372 acquired 3,006 disposed = 5,366 shares) suggests continued alignment with shareholder interests.

Negatives

• Disposition of 3,006 shares, though likely for tax purposes, represents a reduction in direct holdings.

Future Outlook

The filing indicates strong past performance (2023-2025 EPS) but does not provide explicit forward-looking statements or guidance for future periods.

Management Comments

• The company achieved 110% or more of its cumulative earnings per share goal for fiscal years 2023-2025.

Industry Context

StockSavvy.ai notes that strong executive compensation payouts tied to performance metrics like EPS often reflect robust operational execution within the healthcare services sector, especially for large hospital operators like HCA. This suggests HCA maintained strong profitability in a dynamic healthcare environment.

Comparison to Industry Standards

• HCA Healthcare's achievement of 200% vesting for performance share units, based on exceeding 110% of its cumulative EPS target for 2023-2025, indicates superior performance relative to typical industry benchmarks where target achievement often results in 100% vesting.
• This level of performance suggests HCA outperformed many peers in the hospital and healthcare services sector, such as Universal Health Services (UHS) or Tenet Healthcare (THC), which may have faced similar operational challenges but potentially did not achieve the same level of EPS growth.
• The share price of $502.05 at the time of disposition reflects a strong valuation for HCA, potentially indicating market confidence in its business model and financial health compared to other large-cap healthcare providers.

Stakeholder Impact

• Shareholders: Positive signal regarding company performance and executive confidence, potentially reinforcing investor sentiment.
• Employees: May indicate a strong performance culture and potential for performance-based incentives for other employees.

Key Dates

Recommendation

The vesting of performance share units at 200% of target, driven by exceeding cumulative EPS goals for 2023-2025, signals exceptional financial performance and strong operational execution by HCA Healthcare. This indicates robust profitability and effective management, which are key indicators for a "buy" recommendation, suggesting continued confidence in the company's trajectory. The executive's net increase in direct ownership further reinforces this positive outlook.

Keywords

HCA Healthcare, HCA, Form 4, insider trading, stock acquisition, performance shares, executive compensation, Michael R. McAlevey, beneficial ownership